Posted by Michael Wonder on 31 Oct 2021
Prostate cancer treatment to be put on PBS
31 October 2021 - For the first time in seven years, a prostate cancer therapy will be added to the Pharmaceutical Benefits Scheme.
From Monday, men with a high risk form of the disease that no longer responds to traditional testosterone-lowering therapy – known medically as castration resistant prostate cancer – can access Nubeqa (darolutamide) with the support of a Federal Government subsidy.
